GPGerhard Poelzl

Gerhard Poelzl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gerhard Poelzl has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Levosimendan in acute and advanced heart failure: still some chapters to be written

    by Gerhard Pölzl

    The essays in this Supplement to the European Heart Journal emerged from a series of tutorials delivered at the 2018 congress of the European Society of Cardiology (ESC), convened in Munich, Germany. It must be acknowledged at the outset that scope and range of issues addressed during these tutorials considerably exceeded the contents of this Supplement. This is a reflection of the fact that the management of acute heart failure (AHF) and advanced heart failure (AdHF) are among the most complex and challenging aspects of caring for patients with heart failure.


  • Interventional and Medical Treatment of Acute Heart Failure Due to Inflammation

    by Gerhard Poelzl, Matthias Frick, Herwig Antretter, Daniel Hoefer, Christoph Hoermann, Ulrich Schweigmann, Guenther Laufer, Otmar Pachinger

    Four patients (aged 15–41 years, mean age 26.7 years) with fulminant myocarditis undergoing mechanical circulatory support are reported. All patients suffered from acute low-output syndrome refractory to inotropic support. Diagnosis was confirmed by histology and immunohistochemistry. RT-PCR (reverse transcription-polymerase chain reaction) from endomyocardial biopsy specimens revealed parvovirus B19 in two patients and a coinfection with Chlamydia pneumoniae and parvovirus B19 in one patient. Midterm support with the biventricular Thoratec® system was preceded by implantation of an extracorporeal membrane oxygenation (ECMO) device in two patients. Two patients regained full cardiac function and were successfully weaned from the ventricular assist device (VAD) after 12 and 40 days. Heart transplantation was performed in another patient without evidence of myocardial recovery after 53 days. One patient died of cerebral hemorrhage on day 12 after VAD implantation. In summary, patients with life-threatening fulminant myocarditis can be successfully bridged to recovery or transplantation with mechanical circulatory support. Die fulminante Myokarditis ist eine seltene Manifestation der inflammatorischen Kardiomyopathie. Die rasche Entwicklung eines kardiogenen Schocks bzw. ei ner schweren kardialen Dysfunktion kennzeichnet diese Erkrankung. Die Langzeitprognose ist günstig, sofern der Patient die akute Erkrankungsphase überlebt. Berichtet wird über eigene Erfahrungen mit der Implantation mechanischer Unterstützungssysteme bei vier Patienten mit fulminanter Myokarditis. Die Diagnose wurde jeweils histologisch und immunhistochemisch gesichert. Mittels RT-PCR (reverse Transkription-Polymerase-Kettenreaktion) konnte im Myokard von Patientin A (24 Jahre) eine Koinfektion mit Chlamydia pneumoniae und Parvovirus B19, bei zwei Patienten (Patient B männlich, 41 Jahre; Patient C weiblich, 27 Jahre) eine isolierte Infektion mit Parvovirus B19 nachgewiesen werden. Bei Patient D (15 Jahre) fand sich kein Erreger. Patienten A und B erhielten Immunglobuline (2 ×10 g), Patientin A in Kombination mit einem Makrolidantibiotikum. Alle Patienten wiesen eine kurze Erkrankungsdauer mit rascher Entwicklung eines akuten Low-Output-Syndroms auf. Die Implantation des mechani schen Unterstützungssystems erfolgte wegen unzureichender Wirkung der medikamentösen inotropen Unterstützung. Bei zwei Patienten (A, B) wurde zunächst eine extrakorporale Membranoxygenie rung (ECMO) implantiert, welche nach 2 bzw. 4 Tagen durch ein biventrikuläres Unterstützungssystem (BVAD) ersetzt wurde. Zwei Patienten wurden primär mit diesem System versorgt. Bei zwei Patienten (A, D) zeigte sich eine sukzessive Erholung der kardialen Funktion, so dass das Unterstützungssystem nach 12 bzw. 40 Tagen entfernt werden konnte. Beide Patienten wiesen bei der Entlassung eine normale Ventrikelfunktion auf. Patient B wurde nach 53 Tagen wegen fehlender Verbesserung der Pumpfunktion erfolgreich einer Herztransplantation unterzogen. Patientin C verstarb am 12. Tag am Kunstherz an einer Hirnblutung. Als Ursache ist neben der notwendigen Antikoagulanzientherapie ein erworbenes Von-Willebrand-Syndrom anzunehmen. Insgesamt zeigte sich in dieser Serie, dass bei Patienten mit fulminanter Myokarditis mit Hilfe eines mechanischen Unterstützungssystems eine erfolgreiche Überbrückung bis zur Erholung des Myokards bzw. zur Herztransplantation möglich ist.


  • Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function

    by Gerhard Poelzl, Matthias Frick, Benedikt Lackner, Heike Huegel, Hannes F. Alber, Johannes Mair, Manfred Herold, Severin P. Schwarzacher, Otmar Pachinger, Franz Weidinger


  • Open Access

    Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy

    by Gerhard Poelzl, Robert Ullrich, Andreas Huber, Hanno Ulmer, Herwig Antretter, Daniel Hoefer, Thomas Mairinger, Guenther Laufer, Otmar Pachinger, Severin Schwarzacher

    Cardiac allograft vasculopathy (CAV) is a long‐term threat in heart transplant recipients and its exact pathogenesis remains to be established. As complement activation contributes to early and late allograft dysfunction, we hypothesized that deposition of the complement fragment, C4d, in capillaries of cardiac allograft biopsies may be associated with CAV. A polyclonal anti‐C4d antibody was used for immunohistochemistry on endomyocardial biopsies obtained from heart transplant recipients during the first year post‐transplantation. CAV was assessed by intracoronary ultrasound performed at 1‐year post‐transplantation. We were able to show that CAV is highly associated with C4d deposition in capillaries of cardiac allografts and that serial C4d studies may predict development of CAV at 1‐year post‐transplantation.


  • Chronic Heart Failure is Associated with Vascular Remodeling of the Brachial Artery

    by Gerhard Poelzl, Matthias Frick, Heike Huegel, Benedikt Lackner, Hannes F. Alber, Johannes Mair, Manfred Herold, Severin Schwarzacher, Otmar Pachinger, Franz Weidinger

    Aims: Endothelial dysfunction has been shown to correlate with severity of congestive heart failure (CHF) and recent data suggest morphological changes of peripheral vasculature to be associated with the syndrome. We therefore investigated the hypothesis that vascular remodeling is associated with functional changes in peripheral conduit arteries and with systemic overexpression of ET-1 in patients suffering from CHF. Methods and results: 57 consecutive patients referred to the Innsbruck Heart Failure and Transplantation Program (EF=23±7%) and 16 matched controls (EF=60±5%) were studied. Flow-mediated vasodilation (FMD), nitroglycerin-mediated vasodilation (NMD), wall thickness (WT), and incremental elastic modulus (Einc) were assessed by high-resolution ultrasound of the brachial artery. FMD (P=0.004) and NMD (P=0.02) were significantly higher in controls as compared to moderate and severe CHF patients. In contrast, brachial artery-wall thickness (BA-WT) was increased in severe CHF patients (P=0.038). BA-WT was significantly correlated with both FMD (r=−0.28; P=0.049) and NMD (r=−0.38; P=0.003), and with the Einc (r=0.45, P=0.001). Lumen diameter was not different among groups. In patients with BA-WT>0.31 mm, bigET-1 was higher compared to BA-WT<0.31 mm (P<0.05). Conclusion: CHF is associated with remodeling of the brachial artery, which is characterized by morphological, mechanical and functional changes of the vessel wall. Endothelin-1 may play a role in the vascular remodeling process.


  • Bilateral perirenal fluid accumulation associated with Eisenmenger's syndrome

    by Gerhard Pölzl, Karl Lhotta, Martin Tiefenthaler, Alexander Smekal, Silvana Müller


    • 31 October 2002
      • Vol. 114, 833-9

    [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].

    by Gerhard Pölzl, Gazalleh Gouya, Heike Hügel, Matthias Frick, Hanno Ulmer, Otmar Pachinger

    Chronic heart failure is associated with high mortality and morbidity. In spite of a number of trials showing significant improvement in survival and reduction in hospitalization for patients who received ACE inhibitors/AT1 receptor antagonists (ACEI/ARB), beta-blockers and spironolactone, and notwithstanding the recommendations of national and international guidelines for the management of heart failure, substantial proportions of patients are not receiving this treatment. The aim of our study was to analyse 1. the efficiency of a specialized heart failure clinic in translating guidelines into clinical practice, and 2. the effect of optimized neurohormonal therapy on patient outcome. The data of patients with systolic heart failure and an ejection fraction < or = 35% referred to the Innsbruck Heart Failure and Transplantation Program between February 2000 and October 2001 were analysed. The number of patients treated with ACEI/ARB, beta-blocker and spironolactone increased significantly in the investigation period (p < 0.05). Equivalent dose for captopril and bisoprolol per patient developed from 66.4 +/- 42.8 to 96.5 +/- 41.9 mg (p < 0.001) and from 2.0 +/- 2.9 to 6.3 +/- 4.0 mg (p < 0.001), respectively. Optimization of neurohormonal therapy was associated with a significant improvement in NYHA class (2.5 +/- 0.8 vs. 1.9 +/- 0.8; p < 0.001). No relevant changes were noticed for blood pressure, serum creatinine, serum sodium, and serum potassium, whereas heart rate dropped significantly. Kaplan-Meier curves examining the time to first event of the combined end point of mortality and hospitalisation for worsening heart failure revealed a clear benefit for patients on combined neurohormonal therapy (ACEI/ARB and beta-blocker, n = 86) when compared with patients on neurohormonal monotherapy (ACEI/ARB or beta-blocker, n = 35), (p < or = 0.001). Differences remained significant (p = 0.022) after adjusting for NYHA class at referral, age, gender, etiology of the underlying cardiomyopathy, ejection fraction, and atrial fibrillation in Cox regression analysis. Guidelines for the management of chronic heart failure patients can be translated efficiently into clinical practice by a specialized heart failure clinic. Optimization of therapy is associated with an improvement in functional status and a decrease in mortality or hospitalization for worsening heart failure. Therefore the nationwide installation of specialized heart failure clinics is required.


  • Feasibility and Accuracy of Transthoracic Doppler Echocardiographic Estimation of Pulmonary Capillary Wedge Pressure Applying Different Methods

    by Gerhard Poelzl, Martin Gattermeier, Horst Kratzer, Eduard Zeindlhofer, Peter Kuehn

    Background: Pulmonary wedge pressure (PWP) is an established index of cardiac function and an essential component in the management of patients with congestive heart failure and in critically ill patients. Aim: To evaluate feasibility and accuracy of non-invasive prediction of PWP by Doppler echocardiography in daily clinical practice. Methods: Agreement was assessed between values predicted by Doppler vs. invasively measured PWP. Forty-five consecutive patients [mean (S.D.) age 62 (10) years] with CAD (44%), DCMP (40%) and without structural heart disease (16%) were studied (EF ≤ 40% in 58% of the patients). Doppler transmitral and pulmonary venous flow velocity profiles were recorded. For binary and quantitative prediction of PWP, four different methods and five different linear equations, suggested previously in the literature, were evaluated. Results: Predictive values to identify elevated PWP were highest for pulmonary venous flow reversal exceeding the duration of forward mitral flow during atrial systole (PPV 1 and NPV 0.96). Likewise, agreement with measured PWP was highest for equations comprising both transmitral and pulmonary venous flow variables (relative mean difference 0.11, S.D. ± 4.01 mmHg for the most accurate equation). Feasibility was slightly, but not statistically, lower when pulmonary venous flow was considered vs. transmitral flow parameters alone for binary prediction (87 vs. 93%) as well as for quantitative assessment (82 vs. 93%). Conclusion: Semiquantitative prediction of elevated PWP by Doppler echocardiography is feasible as well as accurate in daily clinical practice. However, accuracy of numeric estimates is limited. Hence, invasive measurement of PWP is still necessary in certain clinical settings.